Clinical Trial Update: Cutaneous JAK in Vitiligo and Acne Vulgaris.

View source ↗

Summary

This entry notes an ongoing or planned study investigating cutaneous JAK inhibitors for vitiligo and acne vulgaris, with no status or results details provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Vitiligo

Snippet

Sponsor: Assiut University | Conditions: Vitiligo and Acne Vulgaris | Status: UNKNOWN